When was Pregnolia founded?

Pregnolia was founded in 2015 and raised its 1st funding round 2 years after it was founded.

Where is Pregnolia located?

Pregnolia is headquartered in Zurich, Switzerland.

How many employees does Pregnolia have?

As of Aug 31, 2026, the latest employee count at Pregnolia is 9.

Is Pregnolia a funded company?

Pregnolia is a funded company, having raised a total of $10.2M across 10 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Dec 2017.

When was the latest funding round of Pregnolia?

Pregnolia's latest funding was a $***** Series A round on Nov 21, 2023, with participation from 0 investor. Its primary sector is Women Health. Globally, the Women Health sector has seen $236M in funding in 2026 to date.

Where does Pregnolia rank among its competitors?

Pregnolia ranks 1st amongst 5 active competitors, only 1 of which is funded. Rea Diagnostics, which secured $115K in Jan, 2024.

Who are the top competitors of Pregnolia?

Pregnolia's top competitors include NX Prenatal, Yourgene Health and Rea Diagnostics. Among them, Rea Diagnostics secured the most recent funding round in January, 2024.

Pregnolia - 2026 Company Profile, Team, Funding & Competitors

Pregnolia is a public company based in Zurich (Switzerland), founded in 2015 by Sabrina Badir. It operates as a Provider of device for predicting chances of preterm births. Pregnolia has raised $10.2M in funding. The company has 5 active competitors, including 1 funded and 2 that have exited. Its top competitors include companies like NX Prenatal, Yourgene Health and Rea Diagnostics.

Company Details

Provider of device for predicting chances of preterm births. Its flagship product has a small probe that is used intra-vaginally to measure cervical stiffness. Cervical stiffness has been shown to be a useful parameter for the diagnosis of pre-term birth. The device is currently being validated clinically.

Website: en.pregnolia.com/
Email ID: *****@pregnolia.com

Key Metrics

Founded Year

2015

Location

Zurich, Switzerland

Stage

Public

Total Funding

$10.2M in 10 rounds

Latest Funding Round

Series A, Nov 21, 2023, $*****

Investors

Verve Ventures & 7 more

Ranked

1^st among 5 active competitors

Employee Count

9 as on Aug 31, 2026

Similar Companies

NX Prenatal & 3 more

Exit Details

Public

View Pregnolia's full profile

Pregnolia is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Pregnolia AG CIN: 452.682.851 , Switzerland, Active	Jan 01, 2015	-	-	-

Pregnolia has raised a total funding of $10.2M over 10 rounds. Its first funding round was on Dec 2017. Pregnolia has 8 institutional investors.

Here is the list of recent funding rounds of Pregnolia:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 21, 2023	1170123	Series A	7231463	7425621	3903880	2774890
Dec 31, 2021	8832648	Grant (prize money)	5097732	8519506	6592014	EIC Fund
Nov 30, 2020	7549852	Grant (prize money)	4532536	3789063	6927636	9273184

Access funding benchmarks and valuations. Sign up today!

View details of Pregnolia's funding rounds and investors

The founders of Pregnolia is Sabrina Badir.

Here are the details of Pregnolia's key team members:

Sabrina Badir: Founder & CEO of Pregnolia.
Contact Info: 1 email address

View details of Pregnolia's Founder profiles and Board Members

Pregnolia's employee count trend

Pregnolia has 9 employees as of Aug 26. Here is Pregnolia's employee count trend over the years:

Uncover Pregnolia's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pregnolia include NX Prenatal, Yourgene Health and Rea Diagnostics. Here is the list of Top 10 competitors of Pregnolia, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Pregnolia 2015, Zurich (Switzerland), Public	Provider of device for predicting chances of preterm births	$10.2M	Verve Ventures, Redstone & 6 others	56/100
2nd	NX Prenatal 2010, Louisville (United States), Series A	Provider of early warning blood tests for pregnancy complications	$5.76M	Mindshift Capital, Johnson & Johnson Innovation ... & 8 others	38/100
3rd	Yourgene Health 2000, Manchester (United Kingdom), Late Stage	Provider of non-invasive prenatal genetic tests and genomic services	-	Seneca EIS Portfolio Fund, Calculus Capital ... & 1 others	37/100
4th	Rea Diagnostics 2020, Lausanne (Switzerland), Funding Raised	Provider of a wearable diagnostic device to monitor the risk of preterm birth	-	Venture Kick, FIT & 1 others	34/100
5th	Parsagen Diagnostics 2014, Boston (United States), Acquired	Christian non-profit providing therapeutic riding with volunteer support	$4.05M	LRVHealth, Xandex Investments & 4 others	32/100